AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: It has been demonstrated PI3K/Akt signaling is important in inducing anti-apoptotic effects in chronic myeloid leukemia (21) and that PPAR-γ activation can regulate PI3K/Akt signaling (22).